Markets closed

The Cigna Group

CI · NYSE

Symbol: CI
Type: Stock
Sector: Health Care
Industry: Hospital & Medical Service Plans
Exchange: NYSE

The Cigna Group (NYSE: CI) is a global health company committed to creating a better future built on the vitality of every individual and every community. We relentlessly challenge ourselves to partner and innovate solutions for better health. The Cigna Group includes products and services marketed under Cigna Healthcare, Evernorth Health Services or its subsidiaries. The Cigna Group maintains sales capabilities in more than 30 markets and jurisdictions, and has over 180 million customer relationships around the world.

Key Issues

Bullish view

Cigna delivered an earnings and revenue beat, with Cigna Healthcare fueling growth and both Evernorth and Cigna Healthcare exceeding management expectations in the second quarter.

Bearish view

Higher pharmacy costs remain a specific pressure cited in the earnings coverage and could restrain profit conversion even as operating performance improves.

Analyst Consensus

See all

Buy

21 analysts

$290

Current

—

Low

$340

Average

—

High

Average target implies +17.22% versus the current price.

Earnings History

BeatMissNo estimate

Peers

$290.05+$16.156.10%

Mar 18, 2026 – Sep 11, 2026

$290.05$0.000.00%

· Vol 53.48K

: $280.76
: $76.68B
Open: —
: —
: $284.66 - $290.94
: $239.51 - $315.47
: —
: —
: 1.31M

About The Cigna Group

The Cigna Group is a healthcare company operating through Cigna Healthcare and Evernorth. Cigna Healthcare provides health coverage, while Evernorth supplies health services, including pharmacy-related capabilities; the evidence identifies both businesses as contributors to second-quarter performance but does not provide their revenue proportions. The company serves healthcare customers through this diversified portfolio, although the supplied material does not break out customer types. Cigna generated $274.9 billion of revenue and $6.0 billion of net income in fiscal 2025, compared with $247.1 billion and $3.4 billion, respectively, in fiscal 2024.

Notable Price Movement

Aug 3-7$282.491.23%
The Cigna Group fell $27.01, or 8.97%, from $301.06 to $274.05 over the reported week. Shares declined for four straight sessions through July 31, slipping to $279.05, before a modest rebound to $282.06 on August 3 and a heavier-volume drop to $274.05 on August 4. The main company-specific event was second-quarter reporting: Cigna beat earnings and revenue estimates, Cigna Healthcare supported growth, and management raised its full-year 2026 adjusted earnings outlook again. Those positives were accompanied by higher pharmacy costs, which may have limited the response. The supplied evidence does not identify a separate market-wide catalyst or explain why the stock sold off despite the improved outlook.